We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.38B
AUM Growth
-$459M
Cap. Flow
-$743M
Cap. Flow %
-31.14%
Top 10 Hldgs %
33.74%
Holding
419
New
42
Increased
61
Reduced
145
Closed
52

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$59.1M
2
PGR icon
Progressive
PGR
+$57.1M
3
EL icon
Estee Lauder
EL
+$40.6M
4
META icon
Meta Platforms (Facebook)
META
+$33.8M
5
AAPL icon
Apple
AAPL
+$33.4M

Sector Composition

Rank Sector Weight
1 Technology 34.34%
2 Healthcare 16.07%
3 Consumer Discretionary 11.28%
4 Communication Services 10.91%
5 Industrials 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCC icon
251
Boise Cascade
BCC
$2.96B
$79K ﹤0.01%
+2,160
New +$78.4K
SILC icon
252
Silicom
SILC
$240M
$76K ﹤0.01%
2,270
INSM icon
253
Insmed
INSM
$29.4B
$75K ﹤0.01%
3,150
NTRA icon
254
Natera
NTRA
$45.9B
$74K ﹤0.01%
2,200
SXC icon
255
SunCoke Energy
SXC
$799M
$74K ﹤0.01%
11,957
XLRN
256
DELISTED
Acceleron Pharma
XLRN
$73K ﹤0.01%
1,370
IWF icon
257
iShares Russell 1000 Growth ETF
IWF
$127B
$72K ﹤0.01%
+1,632
New +$68.1K
SHOE
258
Shoe Station Group
SHOE
$437M
$72K ﹤0.01%
3,860
C icon
259
Citigroup
C
$227B
$69K ﹤0.01%
860
+10
+1% +$739
RDUS
260
DELISTED
Radius Recycling
RDUS
$68K ﹤0.01%
3,120
HRTX icon
261
Heron Therapeutics
HRTX
$63.4M
$67K ﹤0.01%
2,840
TTE icon
262
TotalEnergies
TTE
$195B
$67K ﹤0.01%
1,216
+10
+0.8% +$529
ARNA
263
DELISTED
Arena Pharmaceuticals Inc
ARNA
$67K ﹤0.01%
1,470
WFC icon
264
Wells Fargo
WFC
$265B
$65K ﹤0.01%
1,210
+10
+0.8% +$524
RDS.B
265
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$64K ﹤0.01%
1,062
ALLK
266
DELISTED
Allakos
ALLK
$63K ﹤0.01%
+660
New +$58K
BHVN
267
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$63K ﹤0.01%
1,150
NX icon
268
Quanex
NX
$967M
$62K ﹤0.01%
3,650
MNTA
269
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$62K ﹤0.01%
+3,150
New +$50.4K
XNCR icon
270
Xencor
XNCR
$1.6B
$61K ﹤0.01%
1,780
TBRG
271
DELISTED
TruBridge
TBRG
$61K ﹤0.01%
2,300
CEO
272
DELISTED
CNOOC Limited
CEO
$60K ﹤0.01%
360
+10
+3% +$1.53K
IRWD icon
273
Ironwood Pharmaceuticals
IRWD
$669M
$56K ﹤0.01%
4,170
PNC icon
274
PNC Financial Services
PNC
$100B
$56K ﹤0.01%
351
+20
+6% +$3K
NVTA
275
DELISTED
Invitae Corporation
NVTA
$56K ﹤0.01%
3,460

Similar funds

Smith Group Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Smith Group Asset Management held 419 positions worth $2.38B, down 16% from $2.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Smith Group Asset Management withdrew a net $743M in Q4 2019, closing 52 positions and reducing 145 holdings. Its most notable exit was Estee Lauder, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Edwards Lifesciences worth $30.9M.

  • Smith Group Asset Management's largest Q4 2019 buy was Edwards Lifesciences: 397,005 shares worth $30.9M.
  • Smith Group Asset Management added most to Huntington Ingalls Industries in Q4 2019, an estimated $18.2M increase.
  • Smith Group Asset Management's biggest Q4 2019 reduction was Microsoft, cutting an estimated $59.1M.
  • Smith Group Asset Management fully exited Estee Lauder in Q4 2019, selling an estimated $40.6M.
  • Smith Group Asset Management's ten largest holdings make up 34% of its $2.38B portfolio in Q4 2019.
  • Smith Group Asset Management opened 42 new positions and closed 52 in Q4 2019.
  • Smith Group Asset Management's portfolio value fell 16% quarter-over-quarter to $2.38B.

Based on Smith Group Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.